Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
series A
Biotech
Korsana crosses into crowded Alzheimer's field with $175M
Designed to traverse the blood-brain barrier, Korsana plans to debut its anti-amyloid antibody in the clinic early next year.
Darren Incorvaia
Feb 18, 2026 6:00am
Caldera launches with $112M to fund IBD drug from China
Jan 14, 2026 9:10am
Spiro Medical snares $67M series A funding for asthma treatment
Jan 8, 2026 10:50am
Alveus emerges to tackle obesity drug pitfalls with $160M
Jan 8, 2026 7:30am
Fierce Biotech Fundraising Tracker: Syneron, Atavistik & more
Dec 19, 2025 2:00pm
Schizophrenia-minded Syremis takes off with $165M series A
Dec 18, 2025 12:59pm
